France Bed Lowers FY2026 Outlook and Scraps Medium-Term Targets Amid Margin Pressures

The latest announcement is out from France Bed Holdings Co., Ltd. ( (JP:7840) ).

France Bed Holdings has cut its consolidated earnings forecast for the year ending March 31, 2026, trimming expected net sales to ¥61.5 billion and profit attributable to owners of parent to ¥2.65 billion, both below earlier guidance and the prior year. The downgrade reflects weaker demand for high-priced beds amid soft consumer sentiment, a shift toward lower-margin transactions in its medical services business, higher procurement costs driven by a weaker yen, and unplanned structural reform and investment-related expenses, all of which have eroded profitability despite generally steady rental sales. In parallel, the company has withdrawn the performance targets of its medium-term management plan through fiscal 2027, citing significant changes in the consumption environment, cost structure and FX assumptions, and will reassess its earnings scenario, signaling a period of strategic recalibration and elevated uncertainty for investors and other stakeholders.

The most recent analyst rating on (JP:7840) stock is a Buy with a Yen1473.00 price target. To see the full list of analyst forecasts on France Bed Holdings Co., Ltd. stock, see the JP:7840 Stock Forecast page.

More about France Bed Holdings Co., Ltd.

France Bed Holdings Co., Ltd. operates in the home furnishings and medical services sectors, focusing on beds and related durable consumer goods for households as well as rental-based medical and nursing care equipment. Listed on the TSE Prime, the group’s business is closely tied to consumer spending trends and healthcare demand in Japan, making it sensitive to shifts in domestic consumption, cost structures and foreign exchange movements.

Average Trading Volume: 31,455

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen45.96B

See more insights into 7840 stock on TipRanks’ Stock Analysis page.